Healthcare
Live Price
Offline$0.1495
+0.00% today
1Y Change
-42.50%
Window
Jun 30, 2025 → Jun 18, 2026
Coverage: 250 bars · Jun 30, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Brii Biosciences Limited (BRIBF) is a Healthcare stock with a market cap of $840.00M. The stock last traded around $0.15 and down 42.5% across the available one-year price window (Jun 30, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -63.7%, EPS growth of +57.1%, a dividend yield of 0.0%. What stands out right now is revenue -63.7%, EPS +57.1%, free cash flow +23.3% with operating margin -1534.1% and ROIC -12.7%. Valuation already assumes a fairly strong business story at price/sales 43.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BRIBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
BRIBF is 63.36 pts behind over the shared 1Y window.
BRIBF had 33.37 pts deeper max drawdown than SPY.
BRIBF beat SPY in 0 of 2 calendar years shown and trailed in 2.
BRIBF
-42.50%
Normalized return
SPY
+20.86%
S&P 500
Excess Return
-63.36 pts
Relative to SPY
BRIBF Max Drawdown
-42.50%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for BRIBF and SPY.
| Year | BRIBF | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -19.93% | +6.71% | -26.64 pts | SPY |
| 2025 | -28.19% | +11.19% | -39.38 pts | SPY |
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.